Publication | Closed Access

A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma

Hematological MalignancySolid CancersMedicineMalignant Blood DisorderImmunologyHematologyPathologyVehicle-controlled Dose-finding StudyPatients Undergoing ChemotherapyCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentCancer ResearchHealth Sciences